Krishna Institute of Medical Sciences 관리
관리 기준 확인 2/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Abhinay Bollineni
최고 경영자
₹22.0m
총 보상
| CEO 급여 비율 | 77.3% |
| CEO 임기 | 5.3yrs |
| CEO 소유권 | 0.07% |
| 경영진 평균 재임 기간 | 데이터 없음 |
| 이사회 평균 재임 기간 | 2.5yrs |
최근 관리 업데이트
Recent updates
Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 13
There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump
Sep 05We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right
Aug 23Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 10Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?
Jul 02Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon
Jun 12Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?
Apr 28We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
Apr 10Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)
Feb 29Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Jan 23Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist
Nov 21Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?
Aug 23Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)
Aug 02Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher
Apr 01Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital
Dec 14Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report
Aug 13Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency
Aug 12Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors
Jul 02Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected
May 08CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹3b |
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹22m | ₹17m | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹3b |
| Sep 30 2023 | n/a | n/a | ₹3b |
| Jun 30 2023 | n/a | n/a | ₹3b |
| Mar 31 2023 | ₹20m | ₹15m | ₹3b |
| Dec 31 2022 | n/a | n/a | ₹3b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹12m | ₹12m | ₹3b |
| Dec 31 2021 | n/a | n/a | ₹3b |
| Sep 30 2021 | n/a | n/a | ₹3b |
| Jun 30 2021 | n/a | n/a | ₹3b |
| Mar 31 2021 | ₹9m | ₹9m | ₹2b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Mar 31 2020 | ₹8m | ₹8m | ₹1b |
| Mar 31 2019 | ₹5m | ₹5m | -₹477m |
보상 대 시장: Abhinay 의 총 보상 ($USD 260.74K ) Indian 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 611.44K ).
보상과 수익: Abhinay 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Abhinay Bollineni (36 yo)
5.3yrs
테뉴어
₹22,000,000
보상
Dr. Abhinay Bollineni serves as Chief Executive Officer of Krishna Institute of Medical Sciences Limited since July 3, 2019 and has been its Executive Director since January 18, 2019. He holds a bachelor’s...
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | no data | ₹38.67m | 32.25% ₹ 71.6b | |
| CEO & Executive Director | 5.8yrs | ₹22.00m | 0.069% ₹ 152.9m | |
| Director of Operations & Wholetime Director | no data | ₹5.80m | 데이터 없음 | |
| Independent Director | no data | ₹3.52m | 데이터 없음 | |
| Additional Non-Executive & Independent Director | 2.5yrs | ₹1.06m | 데이터 없음 | |
| Independent Director | no data | ₹1.06m | 데이터 없음 | |
| Additional Non-Executive Non-Independent Director | less than a year | 데이터 없음 | 0.010% ₹ 22.5m | |
| Independent Director | no data | ₹1.06m | 데이터 없음 |
2.5yrs
평균 재임 기간
70yo
평균 연령
경험이 풍부한 이사회: KIMS 의 이사회는 경험(평균 재직 기간 2.5 년)으로 간주되지 않으므로 새 이사회가 필요합니다.